Trial intelligence / Profile preview

MEGA versus Kalcipos in adults with vitamin D deficiency

2006-002595-17Phase 3Completed

Sponsor
Meda
Start
Sep 2006
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of calcium carbonate and vitamin d in Vitamin D deficiency (VDD) (2 arms), sponsored by Meda. Primary endpoint: Serum 25-hydroxyvitamin D after 12 months. Started Sep 2006; status: completed.

02

Drugs

calcium carbonatevitamin d
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on 2006-002595-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-002595-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call